Investing.com - Zai Lab (NASDAQ:ZLAB) reported on Thursday second quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Zai Lab announced earnings per share of $-1.74 on revenue of $19.2M. Analysts polled by Investing.com anticipated EPS of $-1.03 on revenue of $9.58M.
Zai Lab shares are up 91.51% from the beginning of the year, still down 10.99% from its 52 week high of $89.48 set on July 9. They are outperforming the Nasdaq which is up 22.73% from the start of the year.
Zai Lab follows other major Healthcare sector earnings this month
Zai Lab's report follows an earnings beat by J&J on July 16, who reported EPS of $1.67 on revenue of $18.34B, compared to forecasts EPS of $1.49 on revenue of $17.61B.
Roche Holding ADR had beat expectations on July 23 with second quarter EPS of $1.45 on revenue of $15.27B, compared to forecast for EPS of $1.42 on revenue of $15.43B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar